v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Convertible preferred stock
Class A and Class B Common stock
Additional paid-in capital
Accumulated other comprehensive income (loss)
Accumulated deficit
Beginning Balance (in shares) at Dec. 31, 2024   245,999        
Beginning Balance at Dec. 31, 2024 $ 1,324,053 $ 329,441 $ 1 $ 1,186,207 $ 1,314 $ (192,910)
Beginning Balance (in shares) at Dec. 31, 2024     214,906      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of stock options (in shares)     154      
Exercise of stock options 339     339    
Stock-based compensation 281     281    
Other (12)     (12)    
Other comprehensive income (loss) 821       821  
Net income (loss) 44,882         44,882
Ending Balance (in shares) at Mar. 31, 2025   245,999        
Ending Balance at Mar. 31, 2025 1,370,364 $ 329,441 $ 1 1,186,815 2,135 (148,028)
Ending Balance (in shares) at Mar. 31, 2025     215,060      
Beginning Balance at Dec. 31, 2025 1,510,641   $ 4 2,950,007 4,003 (1,443,373)
Beginning Balance (in shares) at Dec. 31, 2025     513,043      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of stock options (in shares)     6,597      
Exercise of stock options 28,446     28,446    
Stock-based compensation 170,846     170,846    
Issuance of common stock upon release of restricted stock units (in shares)     10,169      
Shares withheld for taxes upon release of equity awards (in shares)     (3,621)      
Shares withheld for taxes upon release of equity awards (106,400)     (106,400)    
Other comprehensive income (loss) (4,171)       (4,171)  
Net income (loss) (142,401)         (142,401)
Ending Balance at Mar. 31, 2026 $ 1,456,961   $ 4 $ 3,042,899 $ (168) $ (1,585,774)
Ending Balance (in shares) at Mar. 31, 2026     526,188